122 related articles for article (PubMed ID: 38207239)
1. Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System.
Sparano F; Giesinger JM; Gaidano G; Anota A; Cavo M; Brini A; Voso MT; Venditti A; Perrone F; Di Maio M; Luppi M; Baron F; Platzbecker U; Fazi P; Vignetti M; Efficace F
JCO Oncol Pract; 2024 Mar; 20(3):438-447. PubMed ID: 38207239
[TBL] [Abstract][Full Text] [Related]
2. Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemia.
Sparano F; Voso MT; Venditti A; Giesinger JM; Baldi T; Breccia M; Fazi P; Vignetti M; Efficace F
BMJ Support Palliat Care; 2024 May; ():. PubMed ID: 38724222
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
4. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
[TBL] [Abstract][Full Text] [Related]
5. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
[TBL] [Abstract][Full Text] [Related]
6. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
7. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
de Ligt KM; Aaronson NK; Liegl G; Nolte S;
Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
[TBL] [Abstract][Full Text] [Related]
8. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
9. Association of financial toxicity with quality of life in testicular cancer survivors.
Nezu K; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Negoro H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2022 Dec; 29(12):1526-1534. PubMed ID: 36102302
[TBL] [Abstract][Full Text] [Related]
10. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
[TBL] [Abstract][Full Text] [Related]
11. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
[TBL] [Abstract][Full Text] [Related]
12. No impact of Asian ethnicity on EORTC QLQ-C30 scores: Group differences and differential item functioning in paroxysmal nocturnal hemoglobinuria.
Schwartz CE; Stark RB; Borowiec K; Myren KJ
Health Qual Life Outcomes; 2021 Sep; 19(1):228. PubMed ID: 34583705
[TBL] [Abstract][Full Text] [Related]
13. Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer.
Lidington E; Giesinger JM; Janssen SHM; Tang S; Beardsworth S; Darlington AS; Starling N; Szucs Z; Gonzalez M; Sharma A; Sirohi B; van der Graaf WTA; Husson O
Qual Life Res; 2022 Sep; 31(9):2717-2727. PubMed ID: 35476170
[TBL] [Abstract][Full Text] [Related]
14. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
16. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
[TBL] [Abstract][Full Text] [Related]
17. eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting.
Datzmann T; Kisel W; Kramer J; Dreimann M; Müller-Broich JD; Netzer C; Schaser KD; Schmitt J; Disch AC;
BMC Cancer; 2021 Sep; 21(1):1044. PubMed ID: 34556063
[TBL] [Abstract][Full Text] [Related]
18. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
19. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
